Corporate ActionMay 27, 2026, 05:12 PM
TDAC Seeks Shareholder Approval to Extend Merger Deadline to June 2027
AI Summary
Translational Development Acquisition Corp. (TDAC) is holding an Extraordinary General Meeting on June 17, 2026, to seek shareholder approval for extending its business combination deadline. The company proposes to extend the deadline by up to twelve one-month periods, from June 24, 2026, to June 24, 2027, to allow sufficient time to complete its previously announced merger with ProLogium Holding Inc. The extension requires monthly payments into the trust account by the sponsor. Public shareholders have the right to redeem their shares by June 15, 2026, if they do not wish to continue their investment.
Key Highlights
- TDAC seeks to extend business combination deadline from June 24, 2026, to June 24, 2027.
- Extension allows up to twelve 1-month periods, each requiring a sponsor payment into trust.
- Payment is lesser of $200,000 or $0.03 per public share for each 1-month extension.
- Extraordinary General Meeting on June 17, 2026, to vote on extension proposals.
- Merger Agreement with ProLogium Holding Inc. signed on May 27, 2026.
- Proposed Business Combination with ProLogium expected to close in H2 2026.
- Public shareholders can redeem shares by June 15, 2026, 5:00 p.m. ET.
- Company must maintain at least $5,000,001 net tangible assets after redemptions.
Price Impact
More from TDAC